CHATSWORTH, Calif., March 11, 2009 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of urinalysis systems and consumables for use in hospitals and commercial laboratories worldwide, today announced that it will be presenting at Sidoti & Company's 13th Annual Emerging Growth Institutional Investor Forum at 11:00 a.m. Eastern time on Wednesday, March 25, 2009 at The Grand Hyatt Hotel in New York City. Peter Donato, IRIS Corporate Vice President and Chief Financial Officer, will present an overview of the Company followed by Q&A. A copy of the presentation will be available on the Company's web site at www.proiris.com.
About IRIS International
IRIS International is a leading global in vitro diagnostics company focused on products that analyze particles and living cell forms and structures, or morphology of a variety of body fluids. The Company's products leverage its strengths in flow imaging technology, particle recognition and automation to bring efficiency to hospital and commercial laboratories. The initial applications for its technology have been in the urinalysis market and the Company is the leading worldwide provider of urine microscopy systems, with an installed base of more than 2,150 systems in over 50 countries.